Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.
about
Serum peptidome variations in a healthy population: reference to identify cancer-specific peptidesSerum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assaysThrombin induces broad spectrum proteolysis in human serum samples.A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery.Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometryPrediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.Circulating proteolytic products of carboxypeptidase N for early detection of breast cancerAminopeptidase activities as prospective urinary biomarkers for bladder cancer.Development of oleic acid-functionalized magnetite nanoparticles as hydrophobic probes for concentrating peptides with MALDI-TOF-MS analysis.Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.Top-down label-free LC-MALDI analysis of the peptidome during neural progenitor cell differentiation reveals complexity in cytoskeletal protein dynamics and identifies progenitor cell markers.Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.Functional protease profiling for diagnosis of malignant disease.Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.Using a spike-in experiment to evaluate analysis of LC-MS data.Soluble plasma HLA peptidome as a potential source for cancer biomarkersPeptidome analysis of cerebrospinal fluid by LC-MALDI MSMechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.Proteomic profiling of occupational medicamentosa-like dermatitis induced by trichloroethylene in serum based on MALDI-TOF MS.Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.Proteomic study of benign and malignant pleural effusion.Identification of Serum Peptidome Signatures of Non-Small Cell Lung CancerThe use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomasMALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis.Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.Peptidomics analysis of human blood specimens for biomarker discovery.Serum Proteomic Profiles In Subjects with Heavy Alcohol Abuse.Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Thyroid tumors: novel insights from proteomic studies.Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.Salivary peptidomics.Identification of biomarkers for colorectal cancer through proteomics-based approaches.Proteome analysis in thyroid pathology.
P2860
Q28397855-1CFC5CD2-77F5-416A-A9AA-C2471A837629Q28743469-EF2F4622-CE6C-4AFB-A912-9D069AA6ABD8Q30855514-48EC6B35-527A-4E9F-8870-BFE718C972EFQ33305170-E2DC4D38-1828-4747-83F2-33D85344CC19Q33439145-55F2A80C-4E75-473D-94B4-DD409A396A41Q33484162-C23BEDE8-FD0C-4F8F-B37E-6EAE9BB16707Q33499899-F068A8AC-5D43-45DF-88C1-CB65B5B765B4Q33631062-40A0E082-D761-4512-A3D9-E627086F9B58Q33685829-37112956-1D8F-4911-A2BF-B7D3CF2C2530Q33762931-8C37876C-6449-4495-9754-7E90E3BCB693Q33805155-989C50DE-F10C-4690-8C53-36ECDE7691E3Q33877162-92E3B7D0-E3F6-4759-A9D7-BF0C906827DBQ33962226-19DD0705-B57F-4B0D-9472-857CBC2E8923Q33962458-980FE8D8-9CE1-483D-B237-F39BD59C6480Q34116114-05F24B51-420E-4AA5-B8CB-D2E499AF9D89Q34159066-000FD8C0-1048-4E87-B438-E94712AD5ECFQ34166788-CCD6E0F1-44AE-4133-B211-9C17D5397B80Q34173486-A59DE669-EB46-4572-9F9F-4BA5E5D4FFB1Q34279102-3FB18B55-558E-4264-A652-82915E202FAEQ34374324-1D8C959B-D8F1-4C73-9A38-8B854C4E5BE2Q34634913-A6DF56C4-7D33-4FE9-A306-DF683FA42B6FQ35491175-A1A3209F-B51B-452D-9FD6-6FC5AEE52D8BQ35778619-F5194804-AC72-4B56-B184-97BE0EBAB6DAQ35946652-063B4567-74CC-4EA1-BF46-4B6CBB694CFBQ35979222-6397D675-5266-42DA-9742-F66DB5982AD8Q36117662-D59E0909-6F12-4A46-8181-4097A36C135FQ36147848-E9051C4E-B2C3-48A3-A933-E758AED174C4Q36216932-F36D98DE-A97D-4F29-8821-073644883FEDQ36467417-BFBBBA68-4E28-4254-8D57-5B17B0C601EDQ36837041-04F2F972-1732-4A9A-9F12-734FA8E6657EQ36893247-420FFB69-5DC4-40F2-9306-CFF5BD73AB5AQ36950443-554081D6-EEAC-450E-A309-E2D664E50392Q37297757-F62A7987-2E44-4D73-8FED-1A286BDE4A67Q37452720-3D1BB53B-666D-4D92-9B14-E5D71682BA18Q37484011-24C3F724-AE1C-401B-826B-39344B108706Q37579897-83C79DE8-C76A-4167-A435-9B8C09796E38Q37582071-C423D5B8-CEB1-4766-A140-2AA825118845Q37802873-9D8A2F28-8E81-4091-9115-4E7B90BA15D3Q37818315-19F165AC-60AD-4E01-8CC1-D12BE7E064ECQ38541463-9BF5AC6D-1526-443E-87E5-81D5D65A17AF
P2860
Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum peptidome patterns that ...... re unbiased by gender and age.
@ast
Serum peptidome patterns that ...... re unbiased by gender and age.
@en
type
label
Serum peptidome patterns that ...... re unbiased by gender and age.
@ast
Serum peptidome patterns that ...... re unbiased by gender and age.
@en
prefLabel
Serum peptidome patterns that ...... re unbiased by gender and age.
@ast
Serum peptidome patterns that ...... re unbiased by gender and age.
@en
P2093
P1476
Serum peptidome patterns that ...... re unbiased by gender and age.
@en
P2093
Andrew J Martorella
John Philip
Josep Villanueva
Kevin Lawlor
Martin Fleisher
Richard J Robbins
P304
P356
10.1074/MCP.M600229-MCP200
P50
P577
2006-08-08T00:00:00Z